CANADA: Tilray, a global leader in cannabis research, cultivation, production and distribution, announced that its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. has completed a successful harvest of medical cannabis at the Company’s European Union (EU) Campus in Portugal. Tilray’s EU Campus in Portugal is a multi-faceted production facility that includes indoor, outdoor and greenhouse cultivation sites, Read the full article…
CANADA: Aphria has announced that Health Canada has granted the Company its license amendment, permitting Aphria to commence production in an additional 800,000 square feet of facilities at its Aphria One location, as part of the Company’s completed Part IV and Part V expansions. “This is a major milestone for Aphria on its path to becoming a Read the full article…
CANADA: Morganti & Co., P.C., a cross border shareholder’s rights law firm, has commenced a shareholder class action lawsuit against FSD Pharma Inc. for publishing investor documents containing misrepresentations of material fact about the status of its joint venture with Auxly Cannabis Group Inc. between September 29, 2018, and January 7 or February 6, 2019. The shareholders Read the full article…
Cash proceeds of $47 million received, with additional $10 million upon satisfaction of certain conditions CANADA: Aphria announced that independent members of its Board of Directors consisting of Shlomo Bibas, John Herhalt, Tom Looney and Irwin Simon, unanimously approved the early termination and liquidation of a promissory note, option and other agreements related to the Company’s previously announced divestment Read the full article…
CANADA: MediPharm Labs, a leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc. (“MediPharm Labs” or the “Company”), has entered into its first definitive international sales agreement, dated February 20, 2019, with AusCann Group Holdings Ltd. (“AusCann”) to supply private label purified, pharmaceutical Read the full article…
Acquisition unites cannabis pioneer with leading natural food CPG company to create hemp and CBD-infused food and wellness products for North America CANADA: Tilray, a global leader in cannabis research, cultivation, production and distribution, has announced it has entered into a definitive agreement pursuant to which Tilray will acquire all of the issued and outstanding securities Read the full article…
CANADA: Tilray, a global leader in cannabis research, cultivation, production and distribution, announced the closing of a previously announced definitive agreement to acquire all of the issued and outstanding securities of Natura Naturals Holdings, the parent company of a licensed cultivator of cannabis. Moving forward, the Natura facility will operate under the name High Park Read the full article…
CANADA: Newstrike Brands, and its wholly-owned subsidiary, Up Cannabis Inc., announce that an Up Cannabis “Experiential Hub” will be featured prominently in Ontario’s first Spiritleaf store, expected to be located in Kingston, Ontario, in connection with a retail agreement entered into between Spiritleaf and a Ontario cannabis retail lottery winner. Inner Spirit Holdings (“Inner Spirit”) (CSE: ISH) announced earlier today that Read the full article…
CANADA: Patients authorized to legally use medical cannabis frequently substitute it in place of benzodiazepines, according to a pair of new studies. Benzodiazepines are a class of drugs primarily used for treating anxiety. According to data compiled by the US Centers for Disease Control, benzodiazepines were attributed to over 11,500 overdose deaths in 2017. In the first study, Canadian Read the full article…
CANADA: Aphria announced that its Board of Directors has rejected the hostile bid by Green Growth Brands to acquire all of the outstanding common shares of the Company including any Common Shares that may become issued and outstanding after January 22, 2019, but prior to the expiry of the hostile bid upon the exercise, conversion or exchange of options, warrants, Read the full article…